⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 15, 2024Open Access

Supplementary Figure S3 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers

Bhavik Dalal Takeshi Tada Daxesh P. Patel Sharon R. Pine Mohammed Khan Takahiro Oike Yasuyuki Kanke Amelia L. Parker Majda Haznadar Leila Toulabi Kristopher W. Krausz Ana I. Robles Elise D. Bowman Frank J. Gonzalez Curtis C. Harris

View Full Paper

Ask AI

Bookmark

Share

Abstract

Distribution of CR and NANA metabolite levels in early-stage (I & II) cases. ****, p < 0.0001, ***, p < 0.001; ES, early-stage (I & II); x͂ = median

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dalal et al. (2024) studied this question.

synapsesocial.com/papers/68e5c1f0b6db643587559a75 https://doi.org/10.1158/1078-0432.26710914

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers2024
2Supplementary Figure S4 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers2024
3Supplementary Figure S4 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers2024
4Supplementary Figure S2 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers2024
5Supplementary Figure S2 from Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers2024